Search by keywords: and/or Explore by tags: Cancer CareCancer Care › Clinical TrialsCancer Care › DiagnosisCancer Care › Diagnosis › PathologyCancer Care › Genetic TestingCancer Care › Integrative MedicineCancer Care › Integrative Medicine › AcupunctureCancer Care › Medical TechnologyCancer Care › Medical Technology › Bone ScanCancer Care › Medical Technology › CTCancer Care › Medical Technology › MRICancer Care › NursingCancer Care › Pain ManagementCancer Care › Palliative CareCancer Care › Patient Care FacilitiesCancer Care › Prediction ToolsCancer Care › PreventionCancer Care › ScreeningCancer Care › Screening › ColonoscopyCancer Care › Screening › MammographyCancer Care › Screening › PSA TestingCancer Care › TreatmentCancer Care › Treatment › Blood & Marrow Stem Cell TransplantationCancer Care › Treatment › Plastic & Reconstructive SurgeryCancer Care › Treatment › Interventional Radiology Cancer Care › Treatment › Robotic SurgeryCancer Care › Treatment › ChemotherapyCancer Care › Treatment › Gene TherapyCancer Care › Treatment › Hormone TherapyCancer Care › Treatment › ImmunotherapyCancer Care › Treatment › Personalized MedicineCancer Care › Treatment › Radiation TherapyCancer Care › Treatment › SurgeryCancer Care › Treatment › Targeted TherapyCounseling & SupportCounseling & Support › CancerSmartCounseling & Support › Cognitive TestingCounseling & Support › PsychiatryCounseling & Support › Sexual HealthCounseling & Support › Social WorkCounseling & Support › Virtual ProgramsEducation & TrainingMiscellaneousMiscellaneous › FacebookMiscellaneous › WebsiteSurvivorshipSurvivorship › BridgesResearchResearch › Cancer Genetics & GenomicsResearch › Sloan Kettering InstituteResearch › Cancer Immunotherapy & VaccinesResearch › Cancer MetabolismResearch › CellBased TherapyResearch › Cell Signaling & RegulationResearch › Chemical BiologyResearch › Computational OncologyResearch › Developmental BiologyResearch › Discoveries & AdvancesResearch › Discoveries & Advances › Lab ResearchResearch › Discoveries & Advances › Clinical ResearchResearch › Discoveries & Advances › Health Outcomes, Epidemiology & StatisticsResearch › EpigeneticsResearch › Genome IntegrityResearch › Hematologic MalignanciesResearch › ImagingResearch › ImmunologyResearch › Metastasis & Drug ResistanceResearch › Microbiome & InflammationResearch › Molecular Pathology & DiagnosticsResearch › NanotechnologyResearch › Neuroscience & NeuroOncologyResearch › Solid Tumor OncogenesisResearch › Stem Cell BiologyResearch › Structural BiologyResearch › Systems BiologyResearch › Targeted TherapyResearch › Tumor MicroenvironmentGivingGiving › Donating BloodGiving › FundraisingGiving › The Society of MSKCCGiving › Volunteering Upcoming Seminars and Events View upcoming seminars and events. Learn more 16 News Items found Decoder What Is Epigenetics? Tuesday, October 14, 2014 Physician-scientist Omar Abdel-Wahab explains epigenetics, a growing field based on the study of genetic changes that are not part of the DNA code, and how it relates to cancer. Finding Hsp90: A Very Promising Target for Cancer Therapy Thursday, July 17, 2014 A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors. MSK at ASCO Memorial Sloan Kettering’s Expertise in Cancer Immunotherapy Draws Media Focus at 2014 ASCO Meeting Wednesday, June 4, 2014 Our experts offer their perspective in major media outlets on recent research into drug- and cell-based immunotherapies for cancer. In the Clinic New Trial Advances Cell-Based Immune Therapy for Certain Leukemias Thursday, February 20, 2014 A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment. In the Clinic Cell-Based Immune Therapy Shows Promise in Leukemia Patients Wednesday, March 20, 2013 Memorial Sloan Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia. In the Clinic Launch of Stem Cell Therapy Trial Offers Hope for Patients with Inherited Blood Disorder Monday, July 16, 2012 Memorial Sloan Kettering’s trial to evaluate a new therapy for patients with beta-thalassemia is the first to receive FDA approval to treat this disease with genetically engineered cells.